A Look At Visteon (VC) Valuation As Recent Momentum Meets Conflicting Fair Value Views
Visteon Corporation VC | 0.00 |
Visteon stock performance snapshot
Visteon (VC) has drawn investor attention recently after a mixed stretch for the stock, with a small decline over the past day, a modest fall over the past week, and gains over the month and past 3 months.
Looking beyond the latest dip, Visteon’s 1-year total shareholder return of 40.65% versus a weaker 3-year and 5-year total shareholder return suggests recent momentum has picked up compared with its longer track record.
If you are comparing Visteon with other future facing manufacturers, this is a good moment to scan the market using our robotics and automation stock ideas via the 33 robotics and automation stocks
With Visteon trading at US$117.46 and estimates implying roughly 3% upside to a US$121.17 target, plus an indicated intrinsic value gap of about 30%, the key question is whether there is still a buying opportunity here or if markets already price in future growth.
Most Popular Narrative: 1% Overvalued
The most followed narrative puts Visteon’s fair value at about $116, just below the last close at $117.46, which suggests limited upside baked into that view.
The analysts have a consensus price target of $126.857 for Visteon based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $146.0, and the most bearish reporting a price target of just $95.0.
The narrative focuses on steady revenue expansion, a slimmer profit margin profile, and a higher future earnings multiple to support today’s valuation. Curious which assumptions carry the most weight and how sensitive that fair value is to even small shifts in growth or margins? The full narrative breaks down exactly how those moving parts feed into the model.
Result: Fair Value of $116 (OVERVALUED)
However, this depends on tariffs and Chinese demand not becoming more restrictive, since sharper volume declines or higher costs could quickly undermine the current fair value case.
Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.
Another View on Value
While the most popular narrative sees Visteon as roughly 1% overvalued around $117, the SWS DCF model points to a fair value closer to $167.47, which is about 30% above the current price. That is a very different message for anyone weighing risk versus potential upside.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Visteon for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 48 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With mixed signals on value and sentiment throughout this article, it makes sense to check the numbers yourself, move quickly if needed, and weigh the 2 key rewards and 2 important warning signs.
Looking for more investment ideas?
If Visteon is on your radar, do not stop here. Broader ideas can help you stress test your thinking, spot fresh angles, and avoid tunnel vision.
- Target resilience first and review companies in the 63 resilient stocks with low risk scores that may offer steadier profiles when markets turn choppy.
- Hunt for quality at a discount by scanning the 48 high quality undervalued stocks and see which stocks currently trade below their assessed worth.
- Seek robust fundamentals through the solid balance sheet and fundamentals stocks screener (46 results) to find businesses where financial strength underpins the investment case.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
